Curated Business & Technology News from Around the Internet
FEATURED
FDA Clears Starlight Therapeutics' IND Application for Glioblastoma Treatment Trial
Starlight Therapeutics, under Lantern Pharma, receives FDA clearance for a Phase Ib/2a clinical trial of STAR-001 combined with spironolactone, offering new hope for glioblastoma multiforme patients.